Drug
Ganfort clinical trials
- studies test it
- 4
- open now
- 0
- in phase 3
- 1
- first study started
- 2010
How studies write it
Studies that test it under each name
Name
Studies by the year they started
4 studies that test it; most in 2010 (2)
| Year | Studies |
|---|---|
| 2010 | 2 |
| 2011 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 1
- Phase 4
- 2
- No phase
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 0 · Other 4
Aristotle University Of Thessaloniki (1) · University of Campinas, Brazil (1) · Kasr El Aini Hospital (1) · Ministry of Health, Malaysia (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses Ganfort is read from its arms, and is right about nine times in ten.
Testing it · 4
- 24-Hour Intraocular Pressure Control With Bimatoprost/Timolol Versus Latanoprost as First ChoiceCompletedPhase 4Aristotle University Of ThessalonikiNCT01448837Written as Bimatoprost/Timolol, 24-hour intraocular pressure monitoring
- Blood-aqueous Barrier Changes After the Use of Timolol and Prostaglandin Analogues Fixed Combination in Pseudophakic Patients With POAGCompletedPhase 4University of Campinas, BrazilNCT01978015Written as bimatoprost and timolol maleate fixed combination
- Bimatoprost/Timolol Versus Travoprost/TimololCompletedNot applicableKasr El Aini HospitalNCT01542710Written as Ganfort
- A Study of Ganfort Versus Duotrav in Patients With Primary Open Angle Glaucoma or Ocular HypertensionCompletedPhase 3Ministry of Health, MalaysiaNCT01168414Written as Ganfort
As the comparator · 3 — what is tested is compared with Ganfort
- Efficacy and Safety Assessment of T4030 Eye Drops Versus Ganfort® UD in Ocular Hypertensive or Glaucomatous Patients.CompletedPhase 3Laboratoires TheaNCT04898387Written as Bimatoprost Timolol (Ganfort)
- Safety and Efficacy Study of PG324 (Netarsudil/Latanoprost 0.02% / 0.005%) Ophthalmic Solution Compared to GANFORT® Ophthalmic Solution in Open Angle Glaucoma or Ocular HypertensionCompletedPhase 3Aerie PharmaceuticalsNCT03284853Written as GANFORT®
- Safety and Efficacy of a New Formulation of Bimatoprost/Timolol Ophthalmic Solution Compared With Bimatoprost/Timolol Ophthalmic Solution in Patients With Glaucoma or Ocular HypertensionCompletedPhase 3AllerganNCT01177098Written as bimatoprost/timolol fixed combination ophthalmic solution